Tulane National Primate Research Center

描述（由申请人提供）：本申请要求资助杜兰国家灵长类动物研究中心（TNPRC）从2008年5月1日至2013年4月30日的五年期。资金将用于支持中心的行政管理、运营、兽医资源、科研资源以及教育和培训使命。还要求提供额外资金，以支持试点研究项目和与蜂群健康有关的研究资源项目。 近三十年来，TNPRC研究项目的主要重点一直是传染病。这将继续下去。此外，在过去的五年里，与杜兰大学基因治疗中心密切相关的一个重要的基因治疗项目已经开发出来。目前，传染病方案的主要供资领域是艾滋病、莱姆病和生物防御相关制剂;还有一些领域正在开发中，如结核病。这些是多学科研究，涉及TNPRC多个部门的研究人员和中心外的合作者。这些研究涵盖了从传播和发病机制到疫苗策略和化疗治疗的发展。基因治疗计划提供了一个重要的链接到大学的其他部分，允许新的方法来治疗许多类型的疾病，并赋予我们的研究计划额外的多样性。 自上次提交TNPRC基本赠款以来，该中心取得了显著增长和改善。赞助资金总额大幅增加，个人，调查员发起的奖励现在超过了最后一次基本赠款提交时的总奖励。我们目前正在开始对我们的设施进行大规模扩建，以支持不断增长的研究计划。目前项目的总建设预算超过5000万美元，将为该设施增加约80，000平方英尺。扩建工程由众多NIH建筑奖（C 06，UC 6）和私人基金资助。特别值得注意的是区域生物安全实验室。这是一个BSL-3设施，将专注于生物防御和新出现的感染，以支持NIH生物防御研究议程。 基于过去五年的进展，我们对未来非常乐观。我们可以利用的优势包括重大资助的翻新和扩建项目，与NIH和国家优先事项相匹配的研究重点（传染病和基因治疗），教师任命，强大而多样化的研究资源，有才华和敬业的员工，与地区大学的良好互动和合作，以及与我们的主办机构和州和联邦立法者的杰出关系。

Description (provided by applicant): This application requests funding for the Tulane National Primate Research Center (TNPRC) for the five-year period beginning May 1, 2008 through April 30, 2013. Funds will be used to support the administration, operations, veterinary resources, scientific research resources and education and training mission of the Center. Additional funds to support pilot research projects and colony-health-related research resource projects are also requested. For nearly three decades the main focus of the TNPRC research program has been infectious disease. This will continue. In addition, a significant program in gene therapy that is tightly linked to the Center for Gene Therapy at Tulane has developed over the last five years. The major areas of funding for the infectious disease program are currently AIDS, Lyme disease and biodefense-related agents; there are also areas under development, such as tuberculosis. These are multidisciplinary studies involving investigators in multiple Divisions at the TNPRC and collaborators outside the Center. The studies cover the spectrum from transmission and pathogenesis to development of vaccine strategies and chemotherapeutic treatments. The gene therapy program provides an important link to the rest of the University, allows for novel approaches to the treatment of many types of disease and imparts additional diversity to our research program. The period since the last submission of the TNPRC base grant has been a time of significant growth and improvement at the Center. Total sponsored funding has increased dramatically and individual, investigator initiated awards now exceed total awards at the time of the last base grant submission. We are currently at the beginning of a major expansion of our facilities in support of the growing research program. The total construction budget for current projects is in excess of $50M and will add approximately 80,000sf to the facility. The expansion is funded by numerous NIH construction awards (C06, UC6) and private funds. Of particular note is the Regional Biosafety Laboratory. This is a BSL-3 facility that will focus on biodefense and emerging infections in support of the NIH biodefense research agenda. Based on the progress in the last five years we are very optimistic about the future. Strengths on which we can capitalize include significant funded renovation and expansion projects, a research focus (infectious diseases and gene therapy) that matches NIH and national priorities, faculty appointments, strong and diverse research resources, a talented and dedicated staff, excellent interactions and collaborations with area universities and an outstanding relationship with our host institution and state and federal legislators.